The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas

Human Pathology

Volumn 42, Issue 3, 2011, Pages 424-433

  Zheng, Hua Chuan ^a   Xia, Pu ^a   Xu, Xiao Yan ^a   Takahashi, Hiroyuki ^b   Takano, Yasuo ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Colorectal carcinoma; ING5; Pathogenesis; Progression

Indexed keywords

INHIBITOR OF GROWTH 5; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER TISSUE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; TUMOR VOLUME; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMA; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79951581747     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.12.018     Document Type: Article

References (31)

1. Kodama M., Kodama T., and Murakami M. Oncogene activation and tumor suppressor gene inactivation find their sites of expression in the changes in time and space of the age-adjusted cancer incidence rate In Vivo 14 2000 725 734 (Pubitemid 32094086)
2. Gunduz E., Gunduz M., and Beder L.B. Inhibitor of Growth(ING) family: a emerging molecular target for cancer therapy J Hard Tiss Biol 17 2008 1 10
3. Coles A.H., and Jones S.N. The ING gene family in the regulation of cell growth and tumorigenesis J Cell Physiol 218 2009 45 57
4. Unoki M., Kumamoto K., Takenoshita S., and Harris C.C. Reviewing the current classification of inhibitor of growth family proteins Cancer Sci 100 2009 1173 1179
5. Soliman M.A., and Riabowol K. After a decade of study-ING, a PHD for a versatile family of proteins Trends Biochem Sci 32 2007 509 519 (Pubitemid 350008066)
6. Champagne K.S., Saksouk N., and Peña P.V. The crystal structure of the ING5 PHD finger in complex with an H3K4 me3 histone peptide Proteins 72 2008 1371 1376
7. Ullah M., Pelletier N., and Xiao L. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes Mol Cell Biol 28 2008 6828 6843
8. Doyon Y., Cayrou C., and Ullah M. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation Mol Cell 21 2006 51 64 (Pubitemid 43017848)
9. Shiseki M., Nagashima M., and Pedeux R.M. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity Cancer Res 63 2003 2373 2378 (Pubitemid 36605171)
10. Oki E., Maehara Y., Tokunaga E., Kakeji Y., and Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer Cancer Lett 147 1999 157 162
11. Ding H.Z., Yang D., and Wu F.R. p33 (ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues Zhonghua Yi Xue Za Zhi 83 2003 320 323
12. Garkavtsev I., Kozin S.V., and Chernova O. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis Nature 428 2004 328 332 (Pubitemid 38418804)
13. Kim S., Chin K., Gray J.W., and Bishop J.M. A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer Proc Natl Acad Sci USA 101 2004 16251 16256 (Pubitemid 39552831)
14. Wang Y., Dai D.L., Martinka M., and Li G. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma Clin Cancer Res 13 2007 4111 4116 (Pubitemid 47105973)
15. Zhang J.T., Wang D.W., and Li Q.X. Nuclear to cytoplasmic shift of p33 (ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables J Cancer Res Clin Oncol 134 2008 421 426
16. Li M., Jin Y., and Sun W.J. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma J Pathol 219 2009 87 95
17. Shah S., Smith H., Feng X., Rancourt D.E., and Riabowol K. ING function in apoptosis in diverse model systems Biochem Cell Biol 87 2009 117 125
18. Cengiz B., Gunduz M., and Nagatsuka H. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer Oral Oncol 43 2007 241 247 (Pubitemid 46228008)
19. Boyle P., and Leon M.E. Epidemiology of colorectal cancer Br Med Bull 64 2002 1 25 (Pubitemid 35238576)
20. American Cancer Society. Colorectal cancer facts and figures, 2005
21. Yoshida D., Kono S., and Moore M.A. Colorectal polypectomy and risk of colorectal cancer by subsite: the Fukuoka Colorectal Cancer study Jpn J Clin Oncol 37 2007 597 602 (Pubitemid 351790803)
22. Zheng H., Tsuneyama K., and Cheng C. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors Anticancer Res 27 2007 259 265
23. Li X.H., Zheng H.C., Takahashi H., Masuda S., Yang X.H., and Takano Y. PTEN expression and mutation in colorectal carcinomas Oncol Rep 22 2009 757 764
24. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumours, 6th ed 2002 John Wiley & Sons Hoboken (NJ)
25. Hamilton S.R., and Aaltonen L.A. WHO classification of tumors: pathology and genetics of tumors of the digestive system 2000 IARC press lyon
26. Kumada T., Tsuneyama K., Hatta H., Ishizawa S., and Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 2004 1141 1149 (Pubitemid 39128241)
27. Zhang H.K., Pan K., and Wang H. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma Cancer Lett 261 2008 183 192
28. Chen L.S., Wei J.B., and Zhou Y.C. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer World J Gastroenterol 11 2005 6120 6124
29. Kumamoto K., Fujita K., and Kurotani R. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression Int J Cancer 125 2009 1306 1315
30. Zheng H.C., Takahashi H., and Li X.H. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas Virchows Arch 452 2008 147 155
31. Zheng H., Takahashi H., and Nakajima T. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays J Cancer Res Clin Oncol 132 2006 817 823 (Pubitemid 44521458)